Cardinal Health Inc (CAH)
CAH (NYSE:Wholesale)
$47.17

+0.00
+0.00%
Today's Range: 46.60 - 47.37 |
CAH Avg Daily Volume: 3,635,000
| Last Update: 05/24/13 - 4:03 PM EDT |
| Volume: 1,744,714 |
| YTD Performance: 14.55%
|
| Open: $47.03 |
| Previous Close: $47.17 |
| 52 Week Range: $36.91 -
$48.40 |
| Oustanding Shares: 341,823,232 |
| Market Cap: 16,123,801,853 |
6-Month Chart
TheStreet Ratings Grade for CAH
| Buy |
Hold
|
Sell
|
| A+ |
A |
A- |
B+ |
B |
B- |
C+ |
C |
C- |
D+ |
D |
D- |
E+ |
E |
E- |
F |
Analysts Ratings
| Historical Rec |
Current |
1 Mo. Ago |
2 Mo. Ago |
3 Mo. Ago |
| Strong Buy |
5 |
6 |
6 |
6 |
| Moderate Buy |
2 |
2 |
2 |
2 |
| Hold |
3 |
3 |
3 |
2 |
| Moderate Sell |
0 |
0 |
0 |
0 |
| Strong Sell |
0 |
0 |
0 |
0 |
| Mean Rec. |
1.75 |
1.68 |
1.68 |
1.55 |
| Latest Dividend: |
0.30 |
| Latest Dividend Yield: |
2.57% |
| Dividend Ex-Date: |
06/27/13 |
| Price Earnings Ratio: |
14.08 |
|
| Price Earnings Comparisons: |
| CAH |
Sector Avg. |
S&P 500 |
| 14.08 |
14.10 |
17.70 |
| Price Performance History (%Change): |
| 3 Mo |
1 Yr |
3 Y |
|
3.53%
|
13.74%
|
43.46%
|
|
| GROWTH |
12 Mo |
3 Yr |
CAGR |
| Revenue |
4.80 |
0.08 |
0.03 |
| Net Income |
11.50 |
-0.06 |
-0.02 |
| EPS |
12.50 |
-0.04 |
-0.01 |
| Earnings for CAH: |
| EBITDA |
2.19B |
| Revenue |
107.55B |
|
Average Earnings Estimates
;Qtr (09/13);FY (06/13);FY (06/14)&HEADING_LIST1=Qtr (06/12);Qtr (09/12);FY (06/12);FY (06/13)) |
|
| Average Estimate |
$0.77 |
$0.85 |
$3.62 |
$3.54 |
| Number of Analysts |
8 |
8 |
9 |
10 |
| High Estimate |
$0.80 |
$0.92 |
$3.70 |
$3.62 |
| Low Estimate |
$0.75 |
$0.81 |
$3.51 |
$3.47 |
| Prior Year |
$0.73 |
$0.81 |
$3.21 |
$3.62 |
| Growth Rate (Year over Year) |
5.48% |
4.94% |
12.77% |
-2.21% |
Mar 20, 2013 | 8:20 AM EDT
CAH was downgraded to Neutral from Buy, said Citigroup. The loss of the contract with Walgreens will limit earnings growth. Price targe...
Mar 20, 2013 | 7:47 AM EDT
CAH earnings estimates were reduced, said UBS. The loss of the contract with Walgreens was disappointing and makes the CVS contract ren...
Mar 20, 2013 | 7:09 AM EDT
CAH was downgraded from Strong Buy to Buy, ISI Group said. $48.50 price target. Loss of WAG deal will cut into earnings.
| Feb 27, 2013 | 8:30 AM EST
Play things close to the vest for now.
| Feb 19, 2013 | 3:55 PM EST
How much to sell?
Jan 04, 2013 | 6:53 AM EST
CAH was upgraded from Neutral to Buy, Mizuho said. $46 price target. Company will likely renew two major contracts in 2013.
Nov 02, 2012 | 6:15 AM EDT
Cardinal Health, Inc. Annual Shareholder Meeting - 8:30AM
Oct 09, 2012 | 6:53 AM EDT
CAH was upgraded from Market Weight to Overweight, ISI Group said. $46 price target. Stock is already factoring in pricing fears with W...
Aug 03, 2012 | 6:44 AM EDT
Shares of CAH now seen reaching $50, acccording to Credit Suisse. Estimates also reduced, given the company's new guidance. Outperform ...
| Jun 25, 2012 | 12:30 PM EDT
Consensus profit forecasts are in jeopardy.